Pakistan is set to begin local production of insulin in collaboration with Russia, a move officials say will transform the country’s pharmaceutical sector and reduce reliance on costly imports.

Insulin project to mark 'new era'

Special Assistant to the Prime Minister on Finance Haroon Akhtar chaired a meeting of the Drug Regulatory Authority (DRAP) on Thursday where the project was discussed in detail. He called the initiative with Russia a “foundation of a new era,” emphasizing that investment and technology transfer will be at the heart of the joint venture.

“This project will not only improve access to insulin for patients but also create new opportunities for business and scientific cooperation between Pakistan and Russia,” he said.

Phased production and technology transfer

According to Akhtar, insulin will be manufactured in Pakistan in phases, with bulk production expected to begin within the next three years. The agreement includes comprehensive technology transfer, enabling local expertise to gradually scale up manufacturing.

Officials stressed that pharmaceutical companies will be required to comply with strict regulatory conditions to ensure the success and sustainability of the initiative.

Strengthening healthcare and business ties

Beyond improving insulin availability for millions of diabetic patients, the project is also expected to stimulate business cooperation, investment, and research opportunities in the pharmaceutical sector.

“This partnership reflects Pakistan’s commitment to self-reliance in essential medicines while opening doors to broader economic ties with Russia,” Haroon Akhtar added.